Paper12009331
Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappa B) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes.
Liacini A and 3 others. Matrix Biol, 2002. Cited by 351 papers, by iCite.
Cite this record
ConductScience Library. Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappa B) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes. Papers, record 12009331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12009331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappa B) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes.
- PubMed
Topics27
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Collagenases | Major topic |
| Down-Regulation | Major topic |
| Gene Expression Regulation, Enzymologic | Major topic |
| Interleukin-1 | Major topic |
| Matrix Metalloproteinase 3 | Major topic |
| Mitogen-Activated Protein Kinases | Major topic |
| NF-kappa B | Major topic |
| Osteoarthritis, Hip | Major topic |
| Transcription Factor AP-1 | Major topic |
| Animals | |
| Cartilage, Articular | |
| Cattle | |
| Cells, Cultured | |
| Chondrocytes | |
| Curcumin | |
| Enzyme Activation | |
| Enzyme Inhibitors | |
| Femur Head | |
| Humans | |
| Imidazoles | |
| JNK Mitogen-Activated Protein Kinases | |
| Matrix Metalloproteinase 13 | |
| Pyridines | |
| Pyrrolidines | |
| Thiocarbamates | |
| Time Factors | |
| p38 Mitogen-Activated Protein Kinases |
Source PubMed
Cited by126
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 351 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42416050 | Inflammaging and osteoarthritis - therapeutic opportunities. | Front Immunol | 2026 | https://conductscience.org/library/papers/42416050 | PubMed |
| 42256397 | Isoviolanthin suppresses IL-1β-induced inflammatory and catabolic responses in chondrocytes. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42256397 | PubMed |
| 41843133 | Exploration of the therapeutic potential of magnoflorine against osteoarthritis progression using network pharmacology and in vitro validation. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/41843133 | PubMed |
| 41799761 | Artemisia argyi-enhanced Mesenchymal Stem Cell Exosomes Alleviates Inflammation in C28/I2 Chondrocytes by inhibiting NF-κB. | Int J Med Sci | 2026 | https://conductscience.org/library/papers/41799761 | PubMed |
| 41500539 | Interleukin-1β-induced arthritis involves chondrocyte oxiapoptophagy. | Korean J Physiol Pharmacol | 2026 | https://conductscience.org/library/papers/41500539 | PubMed |
| 41023741 | A comprehensive review of curcumin-based scaffolds in cartilage tissue engineering. | Stem Cell Res Ther | 2025 | https://conductscience.org/library/papers/41023741 | PubMed |
| 39568849 | Endothelial-to-mesenchymal transition in the tumor microenvironment: Roles of transforming growth factor-β and matrix metalloproteins. | Heliyon | 2024 | https://conductscience.org/library/papers/39568849 | PubMed |
| 39519121 | The Therapeutic Potential of Exosomes vs. Matrix-Bound Nanovesicles from Human Umbilical Cord Mesenchymal Stromal Cells in Osteoarthritis Treatment. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39519121 | PubMed |
| 39199189 | A Novel BD2-Selective Inhibitor of BRDs Mitigates ROS Production and OA Pathogenesis. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/39199189 | PubMed |
| 38849589 | The emerging role of the semaphorin family in cartilage and osteoarthritis. | Histochem Cell Biol | 2024 | https://conductscience.org/library/papers/38849589 | PubMed |
| 38741587 | Bergamottin (Ber) ameliorates the progression of osteoarthritis via the Sirt1/NF-κB pathway. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/38741587 | PubMed |
| 38718039 | Mume Fructus reduces interleukin-1 beta-induced cartilage degradation via MAPK downregulation in rat articular chondrocytes. | PLoS One | 2024 | https://conductscience.org/library/papers/38718039 | PubMed |
| 37560235 | Down-regulation of Jun induces senescence through destabilizing chromatin in osteoarthritis chondrocytes. | Am J Transl Res | 2023 | https://conductscience.org/library/papers/37560235 | PubMed |
| 37513300 | Anti-Inflammatory Effects of Dietary Polyphenols through Inhibitory Activity against Metalloproteinases. | Molecules | 2023 | https://conductscience.org/library/papers/37513300 | PubMed |
| 37362206 | The role of WNT and IL-1 signaling in osteoarthritis: therapeutic implications for platelet-rich plasma therapy. | Front Aging | 2023 | https://conductscience.org/library/papers/37362206 | PubMed |
| 37189419 | Matrix Metalloproteinases Contribute to the Calcification Phenotype in Pseudoxanthoma Elasticum. | Biomolecules | 2023 | https://conductscience.org/library/papers/37189419 | PubMed |
| 37026251 | Tear proteomics in dry eye disease. | Indian J Ophthalmol | 2023 | https://conductscience.org/library/papers/37026251 | PubMed |
| 35831464 | Glutamine exerts a protective effect on osteoarthritis development by inhibiting the Jun N-terminal kinase and nuclear factor kappa-B signaling pathways. | Sci Rep | 2022 | https://conductscience.org/library/papers/35831464 | PubMed |
| 35806899 | Potential Therapeutic Applications of Natural Compounds in Diabetes-Associated Periodontitis. | J Clin Med | 2022 | https://conductscience.org/library/papers/35806899 | PubMed |
| 35730575 | L-Glutamine alleviates osteoarthritis by regulating lncRNA-NKILA expression through the TGF-β1/SMAD2/3 signalling pathway. | Clin Sci (Lond) | 2022 | https://conductscience.org/library/papers/35730575 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IL1A | 3552 | PubTator's text mining | https://conductscience.org/library/genes/3552 | NCBI Gene |
| JUNB | 3726 | PubTator's text mining | https://conductscience.org/library/genes/3726 | NCBI Gene |
| MAPK1 | 5594 | PubTator's text mining | https://conductscience.org/library/genes/5594 | NCBI Gene |
| MAPK14 | 1432 | PubTator's text mining | https://conductscience.org/library/genes/1432 | NCBI Gene |
| MAPK8 | 5599 | PubTator's text mining | https://conductscience.org/library/genes/5599 | NCBI Gene |
| MMP13 | 4322 | PubTator's text mining | https://conductscience.org/library/genes/4322 | NCBI Gene |
| MMP3 | 4314 | PubTator's text mining | https://conductscience.org/library/genes/4314 | NCBI Gene |
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12009331
GET https://conductscience.org/api/papers/v1/12009331/cited_by?page=2